Covid-19 roundup: BAR­DA hands As­traZeneca $1B-plus to race through PhI­II and ramp up fall de­liv­er­ies of Ox­ford’s pan­dem­ic vac­cine

BAR­DA is dis­patch­ing an­oth­er bil­lion dol­lars-plus for the war on Covid-19, lin­ing up 300 mil­lion dos­es for the US that could start ar­riv­ing as soon as Oc­to­ber.

Al­lied with re­searchers at Ox­ford Uni­ver­si­ty on one of the lead­ing vac­cines now in de­vel­op­ment for Covid-19, As­traZeneca re­port­ed that it has se­cured more than $1 bil­lion from BAR­DA for the de­vel­op­ment, pro­duc­tion and de­liv­ery of the vac­cine, start­ing in the fall. The in­jec­tion dwarfs the ad­di­tion­al £84 mil­lion ($102 mil­lion) in fund­ing for 30 mil­lion dos­es (up to 100 mil­lion dos­es) from the Unit­ed King­dom, which en­vi­sions in­oc­u­lat­ing at least half its pop­u­la­tion by Sep­tem­ber.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER